Laboratorio di Immunologia dei Tumori del Sangue (LITS), Centro Interdipartimentale di Biotecnologie Molecolari "Guido Tarone", Dipartimento di Biotecnologie Molecolari e Scienze della Salute, Università degli Studi di Torino, Torino, Italy.
SC Ematologia, AO S.Croce e Carle, Cuneo, Italy.
Front Immunol. 2023 Jan 16;13:1102471. doi: 10.3389/fimmu.2022.1102471. eCollection 2022.
Myeloid derived suppressors cells (MDSC) play major roles in regulating immune homeostasis and immune responses in many conditions, including cancer. MDSC interact with cancer cells within the tumor microenvironment (TME) with direct and indirect mechanisms: production of soluble factors and cytokines, expression of surface inhibitory molecules, metabolic rewiring and exosome release. The two-way relationship between MDSC and tumor cells results in immune evasion and cancer outgrowth. In multiple myeloma (MM), MDSC play a major role in creating protumoral TME conditions. In this minireview, we will discuss the interplay between MDSC and MM TME and the possible strategies to target MDSC.
髓系来源抑制细胞(MDSC)在许多情况下,包括癌症中,在调节免疫稳态和免疫反应方面发挥着重要作用。MDSC 通过直接和间接机制与肿瘤微环境(TME)中的癌细胞相互作用:产生可溶性因子和细胞因子、表达表面抑制性分子、代谢重编程和外泌体释放。MDSC 与肿瘤细胞之间的这种双向关系导致了免疫逃逸和肿瘤生长。在多发性骨髓瘤(MM)中,MDSC 在形成促肿瘤 TME 条件方面发挥着重要作用。在这篇综述中,我们将讨论 MDSC 与 MM TME 之间的相互作用以及靶向 MDSC 的可能策略。